Lataa...

Augmentation of radiation response by motesanib, a multikinase inhibitor that targets vascular endothelial growth factor receptors

BACKGROUND: Motesanib is a potent inhibitor of VEGFR1, 2 and 3, PDGFR and Kit receptors. In this report we examine the interaction between motesanib and radiation in vitro and in head and neck squamous cell carcinoma (HNSCC) xenograft models. EXPERIMENTAL DESIGN: In vitro assays were performed to as...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Kruser, Tim J., Wheeler, Deric L., Armstrong, Eric A., Iida, Mari, Kozak, Kevin R., van der Kogel, Albert J., Bussink, Johan, Coxon, Angela, Polverino, Anthony, Harari, Paul M.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2010
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3216115/
https://ncbi.nlm.nih.gov/pubmed/20507929
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-09-3385
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!